Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

Abstract Background In stage III non-small cell lung cancer (NSCLC) treated with concomitant chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local and can be treated by stereotactic ablative radiation therapy (SABR). Previous studies reporting outcome after SABR r...

Full description

Bibliographic Details
Main Authors: Shakeel Sumodhee, Pierre-Yves Bondiau, Michel Poudenx, Charlotte Cohen, Arash O. Naghavi, Bernard Padovani, Daniel Maneval, Jocelyn Gal, Axel Leysalle, Hannah Ghalloussi, Josiane Otto, Jérôme Doyen
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Cancer
Subjects:
Stage III non-small cell lung cancer
Stereotactic radiotherapy
Reirradiation
Toxicity
Efficacy
Online Access:http://link.springer.com/article/10.1186/s12885-019-5542-3

Internet

http://link.springer.com/article/10.1186/s12885-019-5542-3

Similar Items